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ABSTRACT 
 
The basic principle of tissue engineering is the combination of appropriate cells 
with biomaterials under conditions that promote and lead to tissue formation. A tissue 
engineering scaffold is a material that supports cells for their growth, proliferation, and 
differentiation in the absence of native extracellular matrix (ECM). The ECM was 
originally thought to provide primarily a mechanical support for the cells, but through 
receptors on the surface of cells, the ECM takes part in promoting cell adhesion, 
migration, growth, differentiation, and apoptosis. Ideally, a tissue engineered scaffold 
should mimic both the form and function of native ECM. Additionally, like any other 
biomaterial for implantation, a tissue engineered scaffold should be biocompatible and 
not initiate tissue reactions or immune responses.  
This work focuses on the evaluation of the biocompatibility of novel alloy-based 
materials for orthopedic applications. In addition, in the context of bone regeneration, it 
examines the influence of select native ECM constituents on mesenchymal stem cell 
(MSC) osteogenic differentiation in 3-D contexts. On the other hand, given the crucial 
role of vasculogenesis in cell nutrition in the scaffolds, ECM mimics found to support 
osteogenesis were further evaluated for endothelial cell adhesion and migration. For the 
hydrogel systems presented in this manuscript, poly(ethylene glycol) diacrylate 
(PEGDA) networks were selected as the base scaffold due to the broad tunability of their 
mechanical properties and their previous use in bone regeneration applications. In 
addition, pure PEGDA hydrogels do not intrinsically promote cell adhesion. Thus, cell 
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interactions with PEGDA gels are initially isolated to the interactions supported by the 
proteins tethered to the scaffold. 
This work attempts to contribute to the development of novel materials that 
provide biocompatibility and enhanced versatility in orthopedic applications. Moreover, 
in the context of bone regeneration, the use of selective ECM biomolecules in hybrid 
hydrogel scaffolds will aid in the understanding of MSC osteogenic responses to specific 
ECM constituents. Additionally, incorporation of ECM mimics that support both 
osteogenesis and vasculogenesis will provide a more controlled platform which will 
serve as a foundation for the fabrication of more efficient vascularized bone constructs.  
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CHAPTER I  
INTRODUCTION  
 
The basic principle of tissue engineering is the combination of appropriate cells 
with biomaterials under conditions that promote and lead to tissue formation. A tissue 
engineering scaffold is a material that supports cells for their growth, proliferation, and 
differentiation in the absence of native extracellular matrix (ECM). The ECM was 
originally thought to act primarily as a mechanical support for the cells, but through 
receptors on the surface of cells, the ECM takes part in promoting cell adhesion, 
migration, growth, differentiation, and apoptosis [1]. Ideally, a tissue engineered scaffold 
should mimic both the form and function of native ECM. Additionally, like any other 
biomaterial for implantation, a tissue engineered scaffold should be biocompatible and 
not initiate tissue reactions or immune responses.  
This work focuses on the evaluation of the biocompatibility of novel alloy-based 
materials for orthopedic applications. In addition, in the context of bone regeneration, it 
examines the influence of select native ECM constituents on mesenchymal stem cell 
(MSC) osteogenic differentiation in 3-D contexts. On the other hand, given the crucial 
role of vasculogenesis in cell nutrition in the scaffolds, ECM mimics found to support 
osteogenesis were further evaluated for their capacity to support endothelial cell 
adhesion and migration. For the hydrogel systems presented in this manuscript, 
poly(ethylene glycol) diacrylate (PEGDA) networks were selected as the base scaffold 
due to the broad tunability of their mechanical properties and their previous use in bone 
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regeneration applications [2-5]. In addition, pure PEGDA hydrogels function as 
biological ‘‘blank slates’’ in that they do not significantly adsorb cell adhesive serum 
proteins and therefore do not intrinsically promote cell adhesion [6]. Thus, cell 
interactions with PEGDA gels are initially isolated to the proteins specifically tethered to 
the scaffold as well as the interactions supported by these proteins. The specific aims and 
rationale for this work were the following: 
 Evaluate the biocompatibility and corrosion resistance of a NiMnSn magnetic 
shape memory alloy (MSMA) in physiological conditions. Recently, magnetic 
shape memory alloys (MSMAs) have emerged as an interesting extension to 
conventional shape memory alloys (SMAs) due to the capacity of MSMAs to 
undergo reversible deformation in response to an externally applied magnetic field. 
As such, MSMAs show substantial promise in biomedical applications for which 
extracorporeal device activation would be desirable or required.  Here we study 
NiMnSn MSMAs because they allow for high actuation stress and greater 
toughness compared to conventional MSMAs while still allowing for 
extracorporeal actuation. However, the cytocompatibility of NiMnSn alloys must 
be evaluated prior to their use in biomedical applications. In the current work, 
NiMnSn MSMA cytotoxicity and its relationship to ion release was evaluated 
using NIH/3T3 mouse fibroblasts encapsulated in 3D poly(ethylene glycol) 
diacrylate (PEGDA) hydrogels in order to mimic the cellular environment provided 
by many implant-contacting tissues. Due to the potential cytotoxicity of Ni and 
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Mn, the effect of a poly(allylamine hydrochloride)/poly(acrylic acid) (PAH/PAA) 
passivation layer on alloy corrosion and cytocompatibility was also evaluated.  
 Elucidate the influence of select ECM constituents on mesenchymal stem cell 
(MSC) osteogenic differentiation in 3-D contexts. We incorporated specific ECM 
molecules into hydrogel scaffolds designed to have moduli within the 
‘‘osteogenic’’ range identified in the 3-D human and mouse MSC studies of 
Huebsch et al. [80]. In selecting molecules for examination, we chose to focus on 
several ECM proteins associated with bone morphogenesis and /or bone fracture 
healing toward the goal of identifying scaffolds with intrinsically osteoinductive 
properties. These proteins were then conjugated into poly(ethylene glycol) 
diacrylate (PEGDA) hydrogel networks. 10T½ MSCs were encapsulated within 
PEGDA hydrogels containing defined amounts of fibronectin (FN), fibrinogen 
(FG) or laminin-1 (LN). The levels of various markers of osteoblast, chondrocytic, 
smooth muscle cell and adipocytic fates were then monitored with time in culture 
toward assessing the strength and specificity of observed osteogenic responses. 
 Evaluate endothelial cell adhesion and migration on biomimetic hydrogels for 
the fabrication of tissue-engineered vascularized bone constructs. The results 
from the previous studies suggested that α1 and α2 integrin cell adhesion is 
probably involved in mesenchymal stem cell osteogenesis. Nonetheless, in this 
particular case, the complexity of the interplay among the multiple signals 
provided to the cells made it difficult to determine whether α1 and α2 integrin 
adhesion was responsible for the differentiation profiles observed. The ideal 
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system for evaluating the effect of a specific signal on cell behavior would allow 
the incorporation of the desired signaling in an appropriate three-dimensional (3D) 
protein structure without the additional signals associated with the biopolymer. 
Recent studies conducted in our lab employed a novel biomaterial platform based 
on a collagen-mimetic protein derived from group A Streptococcus, Scl2.28, which 
maintains the native triple helical structure of native collagen and allows the 
incorporation of desired integrin-binding motifs. Following the development of 
two Scl2 “daughters” (Scl2-2 or DC2, and Scl2-3 or DC3), which incorporate α1β1 
and/or α2β1 integrin-binding motifs based on the collagen sequences GF/LOGER 
[7, 8], our lab has been able to show that hybrid PEGDA-Scl2 hydrogels support 
human MSC (hMSC) osteogenic differentiation, and therefore, have the potential 
to be used as osteoinductive scaffolds. Nonetheless, bone replacement materials are 
more effective if they also support capillary formation in addition to osteogenesis 
[9, 10]. Thus, a bone regeneration scaffold must be able to support endothelial cell 
(EC) adhesion and migration. Therefore, given that DC2 and DC3 incorporate 
α1β1 and/or α2β1 integrin-binding motifs, and that such motifs are involved in EC 
adhesion and phenotype in native vessels, the aim of this study was to evaluate the 
ability of our PEGDA-DC hybrid systems to promote EC adhesion, spreading and 
migration towards the fabrication of improved vascularized bone constructs.  
 
The achievement of these goals attempts to contribute to the development of novel 
materials that provide not only biocompatibility, but also innovative features, such as 
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metamagnetism, which will increase material versatility in orthopedic applications. 
Moreover, in the context of bone regeneration, the use of select ECM biomolecules in 
hybrid hydrogel scaffolds will aid in the understanding of MSC osteogenic responses to 
specific ECM constituents. Additionally, incorporation of ECM mimics such as the Scl2 
proteins, which support both osteogenesis and vasculogenesis, will provide a more 
controlled platform which will serve as a foundation for the fabrication of more efficient 
vascularized bone constructs for orthopedic applications.  
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CHAPTER II 
EVALUATION OF POLYELECTROLYTE COATINGS ON NIMNSN 
METAMAGNETIC SHAPE MEMORY ALLOY CYTOTOXICITY AND ION 
RELEASE  
 
2.1. OVERVIEW 
Recently, magnetic shape memory alloys (MSMAs) have emerged as an 
interesting extension to conventional shape memory alloys (SMAs) due to the capacity 
of MSMAs to undergo reversible deformation in response to an externally applied 
magnetic field. As such, MSMAs show substantial promise in biomedical applications 
for which extracorporeal device activation would be desirable or required.  Here we 
study NiMnSn MSMAs because they allow for high actuation stress and greater 
toughness compared to conventional MSMAs while still allowing for extracorporeal 
actuation.  However, the cytocompatibility of NiMnSn alloys must be evaluated prior to 
their use in biomedical applications. In the current work, NiMnSn MSMA cytotoxicity 
and its relationship to ion release was evaluated using NIH/3T3 mouse fibroblasts. To 
assess cytocompatibility, NIH/3T3 cells were encapsulated in 3D poly(ethylene glycol) 
diacrylate (PEGDA) hydrogels in order to mimic the cellular environment provided by 
many implant-contacting tissues. Due to the potential cytotoxicity of Ni and Mn, the 
effect of a polyelectrolyte passive coating on alloy corrosion and cytocompatibility was 
also evaluated. Results indicate that the use of a poly(allylamine 
hydrochloride)/poly(acrylic acid) (PAH/PAA) passivation layer applied using layer-by-
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layer (LbL) assembly significantly  increased the cytocompatibility of NiMnSn SMAs 
via reducing ion release. To our knowledge, this study presents the first cytotoxicity 
evaluation of NiMnSn MSMAs and lays the groundwork for further biological 
evaluation of these materials.  
 
2.2. INTRODUCTION 
Recently, magnetic shape memory alloys (MSMAs) have emerged as an 
interesting extension to conventional shape memory alloys (SMAs) due to the capacity 
of MSMAs to couple magnetic and electrical energy to mechanical work. Conventional 
SMAs can undergo relatively large recoverable strains as a result of a reversible 
martensitic phase transformation. These recoverable stains can be triggered by changes 
in temperature, leading to actuators, or by stress, leading to pseudoelasticity [11-16]. The 
pseudoelastic response provides a powerful biomedical device design tool unavailable in 
stainless steels and other traditional metallic materials [12] while the actuator response 
allows potential for use in micropumps and displacement-stimulated tissue remodeling. 
However, the need for lead wires and temperature changes for actuation limits the 
potential biomedical applications of these alloys.  
In contrast, MSMAs can undergo reversible deformation in response to an 
externally applied magnetic field [17-22]. As such, MSMAs may hold significant 
promise for biomedical applications where extracorporeal device activation is desirable 
or required. Nickel-Manganese-Gallium (NiMnGa) alloys have been one of the most 
extensively studied MSMA systems [23-30] due in part to their high recoverable strains 
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(up to 10%). Nonetheless, NiMnGa MSMAs tend to be brittle, and the sub-physiological 
temperature range at which NiMnGa alloys displays magnetic shape memory properties 
limits its potential utility in biomedical applications.  
Recently, the alloy ternary series NiMnX (X = Al, In, Sn and Sb) has emerged as 
a class of MSMAs that exhibit higher transition temperatures than NiMnGa alloys, some 
close to physiological temperatures [31, 32]. Additionally, NiMnX alloys have the 
capacity to impose stresses up to 10 times greater than those exhibited by NiMnGa 
alloys and sintered NiMnSn-based alloys show increased toughness [33, 34]. This is due 
to the increased amount of magnetic energy available for actuation in NiMnX MSMAs 
relative to MSMA such as NiMnGa, a trait referred to as meta-magnetism [31]. 
However, the cytocompatibility of NiMnX alloys must be tested in order to further 
evaluate their potential for biomedical applications. This is particularly the case as 
previous in vitro testing has shown NiMnGa to be cytotoxic [35, 36], and a range of 
studies have demonstrated the toxicity of both Ni [37-41] and Mn [42, 43]. In the present 
study, we therefore examined the cytotoxicity of the NiMnSn member of the broader 
NiMnX (X = Al, In, Sn and Sb) MSMA family. Sn was selected over In and Sb as the 
tertiary alloy component due to the high cytotoxicity of In and Sb relative to Mn, Ni, and 
Sn [44] as well as the increased toughness of sintered NiMnSn alloys relative to 
NiMnGa MSMAs [45]. Furthermore, Sn was selected over Al due to the smaller thermal 
hysteresis of the martensitic transformation [46].  
To assess the cytocompatibility of NiMnSn alloys, NIH/3T3 cells mouse 
fibroblasts, a cell line commonly used in cytotoxicity studies [47-50], were encapsulated 
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in three-dimensional (3D) poly(ethylene glycol) diacrylate (PEGDA) hydrogels in order 
to mimic the cellular environment provided by many implant-contacting tissues. 
Furthermore, potential improvements in alloy cytocompatibility following layer-by-layer 
(LbL) application of a poly(allylamine hydrochloride)/poly(acrylic acid) (PAH/PAA) 
were evaluated. Specifically, PAH/PAA coatings have previously been shown to 
significantly improve the corrosion resistance of aluminum [51] and to reduce the 
transport of multivalent ions [52]. Additionally, thin PAH/PAA coatings have also been 
shown to withstand the large cyclic deformations associated with martensitic 
transformation on NiTi substrates [53, 54]. For both coated and uncoated NiMnSn 
MSMAs, cytotoxicity assessments were correlated with alloy ion release measures to 
understand the primary source of observed cytotoxicity. To our knowledge, this study 
presents the first cytotoxicity evaluation of NiMn-based MSMAs with and without a 
polyelectrolyte passive coating. 
 
2.3. MATERIALS AND METHODS 
2.3.1. Alloy fabrication 
Specimens 10x10x1 mm
3
 were cut from NiMnSn pre-alloyed bulk ingots (50 at% 
Ni, 39 at% Mn, and 11 at% Sn) via wire electro-discharge machining (EDM). Similarly, 
10x10x1 mm
3
 specimens were cut from Ni (99.999% pure) and Ti (commercially pure 
grade 2) bulk ingots using EDM. A diamond saw was used to cut 10x10x1 mm
3
 
specimens from Mn (99.9% pure) chips and Sn (99.8% pure) foil. NiMnSn alloys were 
homogenized at 900C for 24 hours under argon in a sealed quartz ampule. All 10x10x1 
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mm
3
 alloy specimens were then polished to a 0.3 μm finish using silicon carbide paper 
followed by alumina colloidal powder on all sides. 
 
2.3.2. Polyelectrolyte coating fabrication  
Two sets of homogenized NiMnSn samples were coated using layer-by-layer 
assembly via dip-coating.  Commercially pure grade 2 Ti wire was glued to one sample 
edge using Loctite M-21HP medical device epoxy (ISO 10993 compliant) to allow even 
dip-coating. Aqueous solutions were prepared using 18.2 MΩ deionized water. 
Individual solutions containing either 0.1 M of PAA (Sigma Aldrich, Mw ~ 100, 000 
g/mol) or 0.1 M PAH (Sigma Aldrich, Mw ~ 15, 000 g/mol) were rolled overnight to 
allow for full dissolution. Both solutions were altered to a pH of 4.5 using 0.1 M NaOH 
solution prior to deposition. Samples were coated with 10 bilayers (BLs) of PAH/PAA 
via LbL processing. One set of coated NiMnSn samples was exposed to 180C for 5 h 
under Ar to induce crosslinking of the PAH/PAA coating, while the second set was not 
exposed to thermal crosslinking.  
To measure coating thickness, P-doped, single-side polished, <1 0 0> silicon 
wafers (University Wafer), each with a thickness of 500 μm, were used as substrates for 
ellipsometric thickness measurements. Film thicknesses were measured using a Model 
alpha-SE Ellipsometer (J.A. Woollman Co., Inc) with a 632.8 nm laser and a 70º 
incidence angle. Thermal crosslinking yielded a reduction in coating thickness - 10 BL 
coatings measured 38.0 nm thick prior to heat treatment and 27.8 nm post treatment.  
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2.3.3. Cell culture studies 
 Cryopreserved NIH/3T3 cells (ATCC) at passage 4 were thawed and expanded at 
37C and 5% CO2. During expansion, cells were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM; Hyclone) containing 5% iron-supplemented bovine calf serum (BCS; 
Hyclone). Cells at passage 8-9 were harvested for the alloy toxicity studies. To evaluate 
the cytocompatibility of the various metal specimens, harvested NIH/3T3 cells were 
encapsulated in 3D PEGDA hydrogels in order to mimic the cellular environment 
provided by many implant-contacting tissues. PEGDA gels were selected for the present 
studies due to their established cytocompatibility and widespread use as 3D culture 
platform [55-57]. The resulting cell-laden hydrogels were then cultured in the presence 
of alloy specimens or metal controls (Ni, Mn, Sn) for a period of 14 days, as described in 
the following sections.   
 
2.3.3.1. Polymer synthesis  
PEGDA was prepared by combining 0.1 mmol/mL dry PEG (6 kDa; Sigma), 0.4 
mmol/mL acryloyl chloride, and 0.2 mmol/mL triethylamine in anhydrous 
dichloromethane (Fisher Scientific) under argon overnight and purified as previously 
described [58]. Cell adhesion peptide NH2-Arg-Gly-Asp-Ser-COOH (RGDS; American 
Peptide) was reacted with acryloyl-PEG-N-hydroxysuccinimide (ACRL-PEG-NHS, 3.4 
kDa; Nektar) at a 1:1 molar ratio for 2 h in 50 mM sodium bicarbonate buffer, pH 8.5. 
The product (ACRL-PEG-RGDS) was purified by dialysis, lyophilized, and stored at -
80C until use.  
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2.3.3.2. Hydrogel preparation and culture 
A hydrogel precursor solution was prepared by dissolving PEGDA at 10 wt% in 
phosphate buffered saline (PBS, pH 7.4; Sigma), after which 10 µl/mL of photoinitiator 
(260 mg/mL of 2-hydroxy-4’-(2-hydroxy-ethoxy)-2-methyl-propiophenone in 70% 
ethanol) was added. ACRL-PEG-RGDS was then dissolved in the precursor solution so 
that the concentration of RGDS in the swollen hydrogels would be 1 μmol/g gel. 
Following sterile filtration of the precursor solution, NIH/3T3 cells were added at 3x10
6
 
cells/mL. This cell suspension was poured into a 1 mm thick rectangular mold and 
polymerized by 6 min exposure to longwave UV light (~6 mW/cm
2
, 365 nm). This 
polymerization process has previously been demonstrated to be cytocompatible and to 
result in gels with homogenously distributed cells [55-57]. The resulting hydrogel was 
removed from the mold, rinsed with PBS, and immersed in DMEM supplemented with 
5% BCS and 1% PSA (PSA: 10,000 U/mL penicillin, 10,000 mg/L streptomycin, and 25 
mg/L amphotericin; Hyclone) at 37C/5% CO2.  
After 24 h to allow for equilibrium swelling, the hydrogel slab was separated into 
uniform gels discs using an 8 mm biopsy punch (Miltex). Each disc was transferred to a 
distinct 12-well culture insert fitted with porous membrane (BD Biosciences). The 
metallic specimens (number of specimens: n = 4 per metallic formulation) were placed 
in the bottom of separate wells of a 12-well culture plate. All metallic surfaces were 
sterilized by immersion in 70% ethanol in water for 1 h and rinsed with sterile de-
ionized water. It is anticipated that room temperature ethanol immersion will have 
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minimal effect on metal surface composition due to the avoidance of oxidative agents, 
irradiation, and heat.  
Following transfer of the gel-laden culture inserts to separate wells of the metal-
containing 12-well plate, 1.5 mL of DMEM supplemented with 5% BCS and 1% PSA 
was added to each well. After 24 h of culture at 37C/5% CO2, the media surrounding 
each sample was fully exchanged, after which full media changes were performed every 
two days. In an initial set of studies, PEGDA hydrogels were exposed to uncoated 
NiMnSn alloys or to Mn, Ni, or Sn controls.  At days 1, 5, and 7 of culture, aliquots of 
culture media were collected from each sample for ion-release analyses prior to 
scheduled media changes. The hydrogel discs were similarly harvested at day 7 for 
comparative cell viability assessments. PAH/PAA-coated and uncoated NiMnSn alloys 
were then compared in a second set of cell culture experiments. In these studies, aliquots 
of culture media were collected from each sample for ion-release analyses prior to 
scheduled media changes at days 1, 7, 10 and 14 of culture. The hydrogel discs were 
similarly harvested at day 14 for cell viability assessments. 
 
2.3.3.3. Ion release 
Levels of Ni, Sn, and Mn ions released from the cultured alloy samples were 
monitored using Inductively Coupled Plasma Emission-Mass Spectroscopy (ICP-MS). 
At the time of analysis, collected media samples were diluted 1:10 v/v with 1% HNO3. 
Ion concentrations were measured using a Perkin Elmer NexION 300 relative to 
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standards prepared from cell culture media containing known amounts of Ni, Sn, or Mn 
(Inorganic Ventures, > 99.89% purity). 
 
2.3.3.4. Cell viability  
Measures of DNA are standardly considered indicators of net cell proliferation 
and death [58]. This is because DNA from dead cells is rapidly degraded (and therefore 
not detected by standard DNA assays) and since each normal somatic cell contains a 
specific amount of DNA. To analyze DNA levels within each metal-exposed hydrogel 
sample, gel discs (n = 4 per metal formulation) collected at the study endpoint were 
digested for 24 h at 37C in 1 ml of 0.1 M NaOH per 0.2 g hydrogel wet weight. The 
samples were then centrifuged (10,000 g for 10 min), neutralized, and their DNA content 
determined using the PicoGreen assay (Invitrogen). Calf thymus DNA (Sigma) 
encapsulated within PEGDA hydrogels and exposed to the same digestion conditions as 
the samples served as a standard.  
 
2.3.4. Statistical analyses 
 Data are reported as mean ± standard error of the mean. Comparison of sample 
means was performed using analysis of variance (ANOVA) followed by a Tukey’s post-
hoc test, p < 0.05 (SPSS software). 
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2.4. RESULTS 
2.4.1. Cell viability and ion release studies 
Cell behavior is often dependent on environmental conditions, and phenomena 
observed in  3D culture systems are not necessarily reflected in 2D culture studies [59, 
60]. Therefore, to more closely mimic the environment of many implant-contacting 
tissues, the cytotoxicity studies were performed on NIH/3T3 cells encapsulated within 
3D PEGDA hydrogels. DNA measures are standardly considered indicators of cell 
viability as cellular DNA is rapidly degraded (and therefore undetected by standard 
assays) following cell destruction. Thus, shifts in sample DNA levels with time reflect 
net cell proliferation and death [56, 58]. Figure 1 shows the results from initial cell 
toxicity studies designed to compare NiMnSn alloy toxicity relative to that of its 
individual components. Viability was significantly lower for cells exposed to NiMnSn 
relative to cells exposed to Sn (statistical significance level: p = 0.004) and relative to 
cells without metal/alloy exposure (“media only” samples, p < 0.001). Similarly, Ni 
samples were as cytocompatible as the PEG-only controls over the culture period of 10 
days. However, cells exposed to pure Mn samples appeared to be of reduced viability 
relative to media only controls, and levels of cell viability in pure Mn samples could not 
be statistically distinguished from those of NiMnSn samples. 
In order to gain insight into the observed cell toxicity results, ion leaching data 
was examined via ICP-MS (Figure 2). In interpreting the data in Figure 2, it is 
important to recall that culture media surrounding the alloys was exchanged every 2 days 
following day 1 of culture. This process was intended to mimic the process of fluid 
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exchange/circulation that occurs in natural body tissues. The Mn ion levels released into 
the NiMnSn culture media over the 7 day culture period were relatively constant at 
approximately 700 ppb. In contrast, ICP-MS revealed an initial burst release of Mn ions 
from the Mn control. However, by day 4, the Mn ion levels released from the NiMnSn 
alloys were approximately 60% of the levels released from pure Mn sample (Figure 
2A).  
 
 
 
Figure 1. (A) Schematic of the cytoxicity testing setup. (B) Cytotoxicity of uncoated NiMnSn 
alloys relative to Ni, Mn, Sn, and culture media (no metal sample) controls as evaluated by DNA 
assessments. For ease of comparison, results are normalized to the media controls. *, 
significantly different from the corresponding Sn, Ni, and media samples, p < 0.05.  
 
 
The release of Ni ions from the NiMnSn samples appeared to be greater than that from 
pure Ni. This may be due to the oxide layer associated with pure Ni acting as a greater 
barrier to Ni release than the oxide layer of NiMnSn. In any case, Ni ion levels in the 
culture media of both Ni metal were approximately 500-650 ppb, whereas that in the 
 17 
 
NiMnSn ranged from 700-900 ppb. Results for Sn ions indicate initial release levels 
around 500-600 ppb that drop continuously over the experimental timeframe. 
 
 
 
Figure 2. Mn, Ni and Sn ion release from the NiMnSn alloys and the Mn, Ni and Sn controls per 
ICP-MS measures. Media surrounding each metal specimen was fully exchanged every 2 days 
beginning at day 1 of culture. 
 
 
Comparison of the present results with existing literature is challenging due to 
the dependency of ion toxicity thresholds on cell type and due to the number of ions 
involved (Ni, Mn, Sn). In comparing our data to literature, we have therefore chosen to 
focus on a cell line of similar sensitivity as NIH/3T3 mouse fibroblasts, namely MC3T3-
E1 mouse cells. MC3T3-E1 mouse cells are one of only two cell types whose viability 
has been evaluated under consistent methods for 43 different metal ions, each ion at 
multiple concentrations. Literature indicates that Sn ions cytotoxicity is not observed for 
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MC3T3-E1 cells until Sn exceeds approximately 2 ppm or 60 ppm, depending on 
whether the Sn ions are 2
+
 or 4
+
 respectively [44].  These results are consistent with the 
high MC3T3-E1 cell viability observed for hydrogels in contact with Sn metal controls, 
where released Sn ions were 10-to-250 fold below these toxicity limits. Similarly, 
literature on Ni ion toxicity indicates that Ni cytotoxic effects on MC3T3-E1 cells begin 
to be observed at fluid levels exceeding 600 ppb [44]. These data appear to explain why 
cell viability remained high in the hydrogels exposed to Ni metal controls, as Ni ion 
levels in the cell culture media hovered at the toxicity threshold. For Mn, literature 
indicates that cell toxicity occurs beyond approximately 550 ppb [44]. The ion release 
from the Mn metal controls exceeded this threshold for all time points, in agreement 
with the reduced cell viability observed in the hydrogels exposed to the Mn control 
samples. In terms of the observed toxicity of the NiMnSn alloys, the ion release data 
suggest that both Ni and Mn ions exceeded the toxicity thresholds by 15 to 54%. As a 
result, both ions likely contributed to the observed reduction in cell viability in hydrogels 
exposed to NiMnSn alloys.   
Steps were therefore implemented to potentially reduce Ni and Mn release. In 
particular, the use of a PAH/PAA passivation layer applied using LbL assembly has 
been shown to significantly improve the corrosion resistance of aluminum [51] and to 
limit the transport of multivalent ions [52]. Also, based on previous work, crosslinking 
the PAH/PAA coating could potentially result in improved corrosion resistance relative 
to an uncrosslinked coating [51, 61]. Therefore, thermal PAH/PAA coating crosslinking 
was also investigated as a possible method to reduce Ni and Mn release and thereby 
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alloy cytotoxicity. The results from the cell viability and ion release studies performed 
on this additional set of samples are shown in Figures 3 and 4, respectively.  
Inclusion of a PAH/PAA coating increased the cytocompatibility of NiMnSn 
MSMAs by approximately 36% (p = 0.018). This was reflected in the reduction of 
approximately 15% Ni and Mn ions released noted for the coated samples relative to the 
uncoated samples (Figure 4). However, crosslinking of this coating appeared to disrupt 
the positive effects associated with the coating itself. Specifically, the cell viability 
associated with alloys with cross-linked coatings could not be statistically distinguished 
from that of uncoated NiMnSn alloys. These results were consistent with the ion release 
data which showed that the reduction in ion release noted for the coated samples was 
largely lost following crosslinking (Figure 4). The impact of the coating on limiting ion 
release is especially apparent when Sn ion levels are examined. Specifically, Sn ion 
release was decreased by approximately 120% in the coated relative to the uncoated 
NiMnSn samples. This substantial reduction in Sn ion release is consistent with the 
increased size and charge of Sn ions (most commonly 4
+
) relative to Mn
2+
 and Ni
2+
 ions, 
as PAH/PAA coatings generally have greater impact on the transport of higher valency 
and larger atomic radius species [52]. Based on literature, it is anticipated that increasing 
the number of PAH/PAA bilayers beyond the current level (10 bilayers) would result in 
further reductions in ion release and thereby improvements in cell viability. However, 
increased bilayer thickness may decrease coating compliance, resulting in delamination 
with cyclic MSMA deformation. Therefore, the coating thickness on shape memory 
 20 
 
alloys must be optimized to obtain the most effective ion barrier while maintaining 
enough compliance to limit delamination due to martensitic transformation strain. 
 
 
 
Figure 3. Cytotoxicity of uncoated NiMnSn alloys relative to NiMnSn alloys with uncrosslinked 
and crosslinked PAH/PAA coatings alloys as evaluated by DNA assessments. For ease of 
comparison, results are normalized to culture media (no metal) controls. *, significantly different 
from the uncoated NiMnSn alloys, p < 0.05. 
 
 
2.4.2. Optical microscopy imaging 
To determine the potential source of the unexpected increased ion release 
associated with coating cross-linking, optical microscopy imaging was performed on the 
uncoated, coated, and crosslinked-coated NiMnSn samples before and after the cell 
cytotoxicity experiments. Figure 5 shows representative images of the various NiMnSn 
samples at day 0 and after 14 days of immersion in cell culture media. For day 0, only 
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one image is provided for each sample type, except for the crosslinked-coated sample. In 
this case, an inset image is included which shows a sample with a defect in the coating.  
 
 
 
Figure 4. Mn, Ni and Sn ion release from uncoated, coated and crosslinked coated NiMnSn 
samples over 14 days of culture. Media surrounding each metal specimen was fully exchanged 
every 2 days beginning at day 1 of culture. 
 
 
For the 14 day time point, two images are provided for each NiMnSn sample type - an 
example of a defect-free location as well as an image of a location where corrosion 
and/or coating degradation was observed. The ridge-like features shown in the day-14 
defect-free image for the crosslinked coated samples are martensite plates resulting from 
the elevated temperature associated with coating crosslinking martensite transformation 
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temperature changes after the crosslinking heat treatment. This shows the potential for 
thermal crosslinking, even at 180C temperatures, to affect alloy response. 
Following 14 days of culture, uncoated samples displayed relatively corrosion-
free regions as well as regions with marked oxidation. This variability could have 
potentially resulted from localized material inhomogeneity that persisted despite the 
homogenization heat-treatment. On the other hand, defect locations in the coated 
NiMnSn samples show surface bubbles indicative of local coating delamination after 14 
days immersion in cell culture media. However, the surface bubbles were generally 
inter-connected and there were no signs of underlying surface corrosion.  
 
 
 
Figure 5. Representative optical microscopy images of uncoated, coated, and crosslinked (x-
linked) coated samples at day 0 and after 14 days of immersion on cell culture media.  Scale bars 
represent 50 µm. The ridge-like features shown in the day-14 defect-free image for the 
crosslinked coated samples are martensite plates resulting from the elevated temperature 
associated with coating crosslinking martensite transformation temperature changes after the 
crosslinking heat treatment.  
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Similar to the coated NiMnSn specimens, the defect regions of the crosslinked-
coated samples showed delamination as indicated by the presence of bubbling of the 
coating surface. In this case however, the bubbles did not interconnect and corrosion 
discoloration was apparent on the underlying metal surface. Importantly, many of the 
day 14 NiMnSn specimens with crosslinked-coatings displayed larger circular regions of 
corrosion where coating was apparently absent. It is believed that many of these larger 
defect regions originated from coating shrinkage during crosslinking that resulted in 
localized defects (Figure 5, inset of day 0 crosslinked-coated samples). These results are 
in contrast to the improved barrier response of crosslinked PAH/PAA films in literature 
[61], and it is believed that improving processing parameters to prevent the observed 
defect formation may the overall cytocompatibility. 
 
2.5. CONCLUSIONS 
The present study was designed to evaluate the cytotoxicity of NiMnSn MSMAs 
as well as the impact of PAH/PAA coatings on NiMnSn cytotoxity. Based on ICP-MS 
measurements, Ni and Mn ion release appears to be the primary source of NiMnSn 
cytotoxicity in the present studies. PAH/PAA coatings appeared to improve the alloy 
cytocompatibility via reducing ion release. Comparison of uncrosslinked and crosslinked 
PAH/PAA coated specimens indicate that coating stability and integrity is critical to 
reducing cytotoxicity. As such, future studies will examine methods, such as chemical or 
UV crosslinking, to improve coating long-term integrity and surface adhesion. 
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CHAPTER III 
INFLUENCE OF SELECT EXTRACELLULAR MATRIX PROTEINS ON 
MESENCHYMAL STEM CELL OSTEOGENIC COMMITMENT IN THREE-
DIMENSIONAL CONTEXTS
*
 
 
3.1. OVERVIEW 
Growth factors have been shown to be powerful mediators of mesenchymal stem 
cell (MSC) osteogenic differentiation. However, their use in tissue engineered scaffolds 
not only can be costly but also can induce undesired responses in surrounding tissues. 
Thus, the ability to specifically promote MSC osteogenic differentiation in the absence 
of exogenous growth factors via the manipulation of scaffold material properties would 
be beneficial. The current work examines the influence of select extracellular matrix 
(ECM) proteins on MSC osteogenesis toward the goal of developing scaffolds with 
intrinsically osteoinductive properties. Fibrinogen (FG), fibronectin (FN) and laminin-1 
(LN) were chosen for evaluation due to their known roles in bone morphogenesis or 
bone fracture healing.  
These proteins were conjugated into poly(ethylene glycol) diacrylate (PEGDA) 
hydrogels and their effects on encapsulated 10T½ MSCs were evaluated. Specifically, 
following 1 week of culture, mid-term markers of various MSC lineages were examined 
                                                 
*
 Reprinted with permission from “Influence of select extracellular matrix proteins on mesenchymal stem 
cell osteogenic commitment in three-dimensional contexts” by Silvia Becerra-Bayona, Viviana Guiza-
Arguello, Xin Qu, Dany J. Munoz-Pinto, Mariah S. Hahn, 2012, Acta Biomaterialia (2012) 4397-4404, 
Copyright 2012, Acta Materialia Inc. Published by Elsevier Ltd.  
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in order to assess the strength and specificity of the observed osteogenic responses. 
PEG–LN gels demonstrated increased levels of the osteogenic transcription factor 
osterix relative to day 0 levels. In addition, PEG–FG and PEG–LN gels were associated 
with increased deposition of bone ECM protein osteocalcin relative to PEG–FN gels and 
day 0. Importantly, the osteogenic response associated with FG and LN appeared to be 
specific in that markers for chondrocytic, smooth muscle cell and adipocytic lineages 
were not similarly elevated relative to day 0 in these gels.  
 
3.2. INTRODUCTION 
Mesenchymal stem cells (MSCs) are being increasingly recognized as a viable 
cell source for bone regeneration applications due to their ability to be expanded in vitro 
and to differentiate into a number of cell lineages. MSC differentiation is known to be 
influenced by a range of environmental stimuli, among the most potent of which are 
growth factors. However, the use of exogenous growth factors in tissue engineering 
scaffolds not only can be costly but also can induce undesired responses in surrounding 
tissues. Thus, MSC-based bone regeneration strategies would benefit from the 
identification of scaffold material properties which intrinsically promote osteoblast 
lineage progression in the absence of exogenous growth factors. 
A number of two-dimensional (2-D) studies have demonstrated MSC osteogenic 
differentiation to be tightly regulated by cellular interactions with the surrounding 
extracellular matrix (ECM) [62-74]. However, comparatively, little is known regarding 
the effects of various ECM components in regulating MSC osteogenesis in three-
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dimensional (3-D) scaffold environments [75-77]. This is significant since recent studies 
suggest that effects observed in two dimensions may not be indicative of the effects of 
the same scaffold variables in more biomimetic 3-D culture systems [78-80].Therefore, 
the current work focuses on elucidating the influence of select ECM constituents on 
MSC osteogenic differentiation in 3-D contexts.  
Towards this goal, we incorporated specific ECM molecules into hydrogel 
scaffolds designed to have moduli within the ‘‘osteogenic’’ range identified in the 3-D 
human and mouse MSC studies of Huebsch et al. [81]. In selecting molecules for 
examination, we chose to focus on several ECM proteins associated with bone 
morphogenesis (fibronectin [82] and laminin-1 [83, 84]) and/or bone fracture healing 
(fibrinogen [85]). These proteins were then conjugated into poly(ethylene glycol) 
diacrylate (PEGDA) hydrogel networks. PEGDA hydrogels were selected as the base 
scaffold due to the broad tunability of their mechanical properties and their previous use 
in bone regeneration applications [2-5]. In addition, pure PEGDA hydrogels function as 
biological ‘‘blank slates’’ in that they do not significantly adsorb cell adhesive serum 
proteins and therefore do not intrinsically promote cell adhesion [6]. Thus, cell 
interactions with PEGDA gels are initially isolated to the proteins specifically tethered to 
the scaffold as well as the interactions supported by these proteins (e.g. growth factor 
binding). 
In the present study, 10T½ MSCs were encapsulated within PEGDA hydrogels 
containing defined amounts of fibronectin (FN), fibrinogen (FG) or laminin-1 (LN). The 
levels of various markers of osteoblast, chondrocytic, smooth muscle cell and adipocytic 
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fates were then monitored with time in culture toward assessing the strength and 
specificity of observed osteogenic responses.  
 
3.3. MATERIALS AND METHODS 
3.3.1. Polymer synthesis and characterization 
3.3.1.1. PEG diacrylate synthesis 
PEGDA was prepared as previously described [86] by combining 0.1 mmol ml
-1
 
dry PEG (10 kDa, Fluka), 0.4 mmol ml
-1
 acryloyl chloride and 0.2 mmol ml
-1
 
triethylamine in anhydrous dichloromethane and stirring under argon overnight. The 
resulting solution was washed with 2 M K2CO3 and separated into aqueous and 
dichloromethane phases to remove HCl. The organic phase was subsequently dried with 
anhydrous MgSO4, and PEGDA was precipitated in diethyl ether, filtered and dried 
under vacuum. Acrylation of the PEG end hydroxyl groups was characterized by proton 
nuclear magnetic resonance (1H-NMR) to be ~95%. 
 
3.3.1.2. Synthesis of acrylate-derivatized proteins 
Proteins FN (human plasma, BD Biosciences), FG (human plasma, Sigma 
Aldrich) and LN (mouse, BD Biosciences) were lightly functionalized in their folded 
state by reaction with acryloyl-PEG-N-hydroxysuccinimide (ACRL-PEG-NHS, 3.4 kDa, 
Nektar) at a 1:2 M ratio at pH 8.5 [86]. The resulting acrylate-derivatized products were 
purified by dialysis against a 100 kDa membrane, lyophilized and stored at -20 °C until 
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use. ACRL–PEG conjugation to the target proteins was confirmed using 1H-NMR. A 
representative 
1
HNMR spectrum for acrylate-derivatized FG is shown in Figure 6.  
 
 
 
Figure 6. 
1
HNMR spectrum of functionalized FG confirming conjugation of FG with ACRL-
PEG-NHS. 
 
 
To confirm the ability of the modified proteins to be incorporated within PEGDA 
hydrogel networks, hydrogel precursor solutions were prepared with 0.5 mg ml
-1
 protein 
and 100 mg ml
-1
 PEGDA (10kDa). Following the addition of 10 µl ml
-1
 of a 300 mg ml
-1
 
solution of UV photoinitiator 2,2-dimethoxy-2-phenyl-acetophenone (DMAP) in N-
vinylpyrrolidone (NVP), gels were polymerized by 4 min exposure to long-wave UV 
light (Spectroline, ~6 mWcm
-2
, 365 nm). The gels were then immersed in PBS 
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overnight, after which they were transferred to a 0.12 M NaOH solution to hydrolyze the 
PEGDA crosslinks and release encapsulated protein. The levels of protein released were 
compared to the levels in the precursor solution using the CBQCA assay (Invitrogen), 
and the average level of protein incorporation was found to be consistent across protein 
types at 86.7 ± 7.2%. In addition, to assess the ability of cells to interact with proteins 
incorporated into the hydrogel network, 10T½ cells were seeded onto the surface of each 
gel formulation. Cell adhesion and spreading were confirmed for each PEG–ECM gel 
type (Figure 7). 
 
 
 
Figure 7. PEG-functionalized protein hydrogels were fabricated by combining 100 mg ml-1 
PEGDA (10kDa) with photoinitiator (DMAP in NVP) and 0.5 mg ml-1 functionalized protein of 
FG, FN and LN. PEGDA hydrogel served as a negative control. 10T½ cells were stained with 
5µM CellTracker Orange CMTMR (5-(and-6)-(((4-chloromethyl) benzoyl) amino) 
Tetramethylrhodamine) and seeded at a density of 6000 cells/cm2 on the surface of the 
hydrogels. Attached cells were allowed to spread for 3 hours and imaged by fluorescence 
microscopy. The scale bar applies to all images and equals 20 µm.  
 
 
3.3.2. Cell culture, initial characterization and encapsulation  
Cryopreserved 10T½ mouse MSCs (American Type Culture Collection; ATCC) 
at passage 2 were thawed and expanded in monolayer culture per ATCC protocols. Prior 
to encapsulation, cells were maintained at 37 °C and 5% CO2 in Dulbecco’s modified 
Eagle’s medium (DMEM, Hyclone) supplemented with 10% heat-inactivated fetal 
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bovine serum (FBS, Hyclone). Cells at passage 4–6 were termed ‘‘day 0’’ and were 
harvested and allocated for either protein extraction or hydrogel encapsulation. 
 
3.3.2.1. Protein extraction 
Proteins were extracted from day 0 10T½ cells by the addition of Trizol 
(Invitrogen) per manufacture’s protocols. The resulting solutions were centrifuged, and 
each supernatant was mixed with chloroform (Sigma), vigorously shaken for 15 s and 
centrifuged. The lower protein-rich phenol–chloroform phase of each sample (n = 4) was 
mixed with ethanol to precipitate residual DNA. The resulting phenol–ethanol phase was 
transferred to a 3.4 kDa SnakeSkin dialysis membrane (Pierce). The solution was 
dialyzed for ~60 h at 4 °C against an aqueous solution of 0.1% sodium dodecyl sulfate 
(SDS), with buffer exchange every 18 h. By the end of the third 18 h dialysis period, the 
samples had partitioned into three phases: (1) a supernatant, (2) a globular mass and (3) 
a colorless, viscous liquid. The globular mass, containing the bulk of sample proteins 
[87], was resuspended in PBS containing 0.5% SDS and 1% Triton X-100. The isolated 
sample proteins were subsequently used in quantitative ELISA assays. 
 
3.3.2.2. Cell encapsulation and culture 
Hydrogels were fabricated by preparing: (1) a 20 wt.% PEGDA solution in 
HEPES-buffered saline (HBS) and (2) separate solutions of 1 mg ml
-1
 acrylate-
derivatized FN, FG or LN in HBS. A 300 mg ml
-1
 solution of DMAP in NVP was added 
at 2% (v/v) to the PEGDA mixture. The PEGDA and protein solutions were then 
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separately sterilized by filtration, after which each protein solution was mixed with an 
equal volume of the 20 wt.% PEGDA solution. Harvested 10T½ cells were resuspended 
in the resulting precursor solutions at 1 x 10
6
 cells ml
-1
. The cell suspensions were then 
pipetted into molds composed of two glass plates separated by 0.5 mm polycarbonate 
spacers and polymerized by 4 min exposure to long-wave UV light (Spectroline, 
~6mWcm
-2
, 365 nm). A set of the resulting hydrogels were harvested for ‘‘day 0’’ 
analyses as described in the following section. The remaining hydrogel slabs were 
transferred to Omnitrays (Nunc) fitted with four sterile polycarbonate bars to 
simultaneously prevent gel flotation and prevent gel contact with the tray bottom. 
Hydrogels were immersed in DMEM supplemented with 10% FBS, 100 U ml
-1
 
penicillin and 100 mg l
-1
 streptomycin. Gels were maintained at 37 °C and 5% CO2, with 
media changes every 2 days. 
 
3.3.3. Day 0 hydrogel characterization 
3.3.3.1. Average mesh size 
PEGDA hydrogel mesh structure cannot be visualized using standard techniques 
such as scanning electron microscopy. In the present study, average hydrogel mesh size 
was therefore characterized via a series of dextran diffusion experiments based on an 
adaptation of the methodology of Watkins and Anseth [88]. In brief, samples were 
collected from the freshly prepared PEG– ECM hydrogels and allowed to swell 
overnight at 37 °C in PBS containing 0.05% azide (PBS-azide). Eight-millimeter-
diameter discs were then harvested from each gel formulation, and solutions containing 
 32 
 
0.05 mg ml
-1
 fluorescently labeled dextran (10 kDa, Invitrogen) in PBS-azide were 
added at 1 ml per hydrogel disc. Dextran solutions were allowed to diffuse into the 
hydrogels for 24 h at 37 °C. Each gel disc was then gently blotted and transferred to 1 ml 
fresh PBS-azide. Dextran that had penetrated into the hydrogels was then permitted to 
diffuse out into the surrounding solution at 37 °C. After 24 h, the fluorescence of the 
PBS-azide solution surrounding each disc was measured at ex/em 488/532. Dextran 
standard curves were used to convert each fluorescence signal to a concentration. For 
each hydrogel, the measured dextran concentration was divided by gel weight [89]. The 
resulting value served as a quantitative indicator of hydrogel permissivity. 
 
3.3.3.2. Hydrogel mechanical properties 
Samples were collected from each freshly prepared hydrogel formulation and 
allowed to swell overnight in PBS-azide. Eight mm discs (n = 4 per formulation) were 
then cored from each gel sample and mechanically tested under unconfined compression 
using a DMA 800 (TA Instruments). Following application of a 0.01 N preload, each 
disc was subjected to compression at a rate of 0.1 mm min
-1
. The compressive modulus 
of each hydrogel was extracted from the resulting stress–strain data over a 10–25% 
strain range. 
 
3.3.3.3. Cell density 
Samples (n = 4) were collected from each freshly prepared hydrogel formulation 
following 24 h immersion in culture media. Hydrogel samples were digested for 72 h at 
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37 °C in 1 ml of 0.12 M NaOH per 0.2 g hydrogel wet weight [90, 91]. Aliquots of the 
hydrolyzed samples were neutralized, and their DNA content determined using the 
Invitrogen PicoGreen assay [92]. DNA measures were translated to cell number using a 
conversion factor of 6.6 pg DNA per cell [93]. Calf thymus DNA (Sigma) subjected to 
the same association with PEGDA and to the same digestion conditions as the samples 
served as a standard. 
 
3.3.4. Endpoint analyses 
At day 7 of culture, samples were harvested from each hydrogel formulation for 
mechanical, mesh size, DNA, ELISA and histological analyses. Samples collected for 
histological analyses (n = 4–8 per formulation) were fixed in 10% formalin for 30 min 
and embedded in Tissue-Tek freezing medium. Samples harvested for mechanical (n = 4 
per formulation), mesh size (n = 4 per formulation) and DNA (n = 4 per formulation) 
assessments were evaluated according to the same protocols as the day 0 specimens. 
Similarly, samples harvested for ELISA analyses (n = 6–9 per formulation) were 
homogenized in Trizol using a Bead-Beater homogenizer (Biospec), after which sample 
proteins were isolated as described for day 0 specimens. 
 
3.3.4.1. ELISA analyses 
Proteins extracted from the day 0 cells and the day 7 constructs were evaluated 
for various lineage markers and integrin alpha subunits via competitive ELISAs. For 
each antibody examined, high binding EIA 96-well plates (Costar) were coated 
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overnight at 4 °C with appropriate competitive peptide. The concentration of applied 
competitive peptide was 200 ng per well, except for b-actin (50 ng per well). The coated 
wells were then blocked with BSA and rinsed with PBS. Aliquots of each sample were 
incubated with primary antibody for 1 h, after which the sample–antibody mixtures were 
applied to coated wells for 1 h. Standard curves were similarly prepared by incubating 
primary antibody with varying levels of competitive peptide for 1 h, followed by 
solution application to coated wells. For both samples and standards, primary antibody 
which had bound to the coated wells was detected using an appropriate HRP-conjugated 
secondary antibody (Jackson Immunoresearch), followed by the application of 2,20-
azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (Sigma) and monitoring of absorbance 
at 410 nm. Each target protein was analyzed in duplicate for each sample (n = 6–9 per 
day 7 gel type; n = 4 for day 0) and normalized to the housekeeping protein b-actin. 
 
3.3.4.2. Histological analyses 
Bone ECM deposition (osteopontin and osteocalcin) was further analyzed using 
standard immunohistochemical techniques. In brief, 35 µm sections were cut from each 
embedded histological sample (n = 4–8 per formulation) using a cryomicrotome. 
Rehydrated sections were blocked for peroxidase for 30 min followed by 30 min 
exposure to Terminator (Biocare Medical). Primary antibodies for osteopontin and 
osteocalcin were diluted in PBS containing 3% BSA and then applied to the sections for 
1 h. Bound primary antibody was detected using HRP-conjugated secondary antibody 
(Jackson Immunoresearch) followed by the application of chromogens AEC (LabVision) 
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or DAB (Biocare Medical). For the detection of intracellular differentiation markers 
(myocardin and PPARγ), rehydrated sections were permeabilized (10 mM HEPES, pH 
6.8, 100 mM NaCl, 3 mM MgCl2, 300 mM sucrose, 0.5% Triton X-100) for 30 min prior 
to Terminator application.  
 
 
 
Figure 8. Comparison of osteocalcin measures by ELISA and cell counting assessments. For 
ELISA assays, 6-9 samples per formulation were analyzed. For cell counts, sections from 4 
separate discs of each formulation were evaluated.  The degree of correlation between the two 
assessment techniques was 98.5% by Pearson’s correlation coefficient method  
 
 
Stained sections were imaged using a Zeiss Axiovert microscope, and cell counts 
were carried out to semi-quantitatively evaluate immunostaining results for intracellular 
markers myocardin and PPARγ. These counting assessments were conducted according 
to established methods [2, 94, 95] on sections from each sample (n = 4–8 per gel 
formulation). For each cell, i, in a given section, a single observer blinded to outcome 
assigned a staining intensity, di, on a scale of 0–3 (0 = ‘‘no staining’’ and 3 = ‘‘highest 
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intensity among all formulations for that antibody’’). The cumulative staining intensity, 
d, for a given antibody in a particular section was calculated using the following 
equation: d = (∑  )/(total cell number). In addition, since deposited ECM remained 
localized around the parent cells in each hydrogel formulation, as is characteristic for 
PEGDA gels [96], the relative levels of osteocalcin and osteopontin among hydrogel 
formulations were also evaluated by cell counts per the above procedure. Osteocalcin 
counts were used to internally validate the counting approach by direct comparison with 
corresponding quantitative ELISA data (Figure 8). The degree of correlation between 
the two assessment techniques was 98.9% by Pearson’s correlation coefficient method. 
 
3.3.5. Statistical analyses 
Data are reported as mean ± standard deviation. Comparison of sample means 
was performed by ANOVA followed by Tukey’s post hoc test (SPSS software), p < 
0.05. 
 
3.4. RESULTS 
3.4.1. Hydrogel material properties and cell density 
A range of scaffold properties, including modulus, permeability and degradation 
rate, have been found to impact MSC lineage progression. Therefore, in order to 
attribute differences in 10T½ cell behavior across hydrogel formulations specifically to 
initial differences in gel protein composition, it was important that the remaining 
hydrogel material properties could be considered consistent across gels. Hydrogels 
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formed from pure PEGDA degrade slowly (over a period of 1–2 years) and resist cell-
mediated gel contraction, ensuring consistent bulk gel properties over a broad time range 
[91, 92, 97-99]. In the present study, a 200:1 weight ratio of PEGDA to protein was 
therefore selected to ensure that the network properties of the resulting gels would be 
dominated by PEGDA. To confirm this, the modulus, mesh size, thickness and mass of 
the PEG–ECM hydrogels were characterized both at day 0 and at day 7. 
As shown in Table 1, the initial elastic moduli of the PEG–FG, PEG–FN and 
PEG–LN gels were similar at ~33 kPa. Importantly, each of these initial moduli were 
within the osteogenic range identified by the 3-D studies of Huebsch et al. [81]. To 
assess degradation and cell-mediated contraction, hydrogel modulus and thickness were 
evaluated across time in culture. Comparison of initial and endpoint mechanical data 
indicated that, although the modulus decreased by ~15% over the 7 day culture time for 
each gel formulation, hydrogel modulus remained consistent across formulations (Table 
1). Similarly, average mesh size was consistent across hydrogels at both day 0 and day 7 
(Table 1). 
 
 
Table 1. Comparison of the average modulus and mesh size of 8 mm discs of each PEG–ECM 
hydrogel formulation with time in culture.
a 
 
 
 
a
 Property results represent an average of n = 4 samples for each PEG-ECM formulation 
*
 Significantly different from the corresponding day 0 value, p < 0.05. 
 
Gel type 
Modulus (kPa) Mesh size (µg dextran/g-gel) 
Day 0 Day 7 Day 0 Day 7 
PEG-FN 33.3 ± 0.7 29.2± 0.8
*
 11.8 ± 0.3 12.4± 0.3 
PEG-FG 33.9 ± 1.9 29.9± 1.5
*
 11.4 ± 0.3 11.7± 0.2 
PEG-LN 33.7 ± 2.0 28.7± 1.2
*
 11.6 ± 0.3 11.8± 0.6 
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The initial and endpoint thickness data for 8 mm gel discs indicated a negligible 
alteration in gel volume with time. In addition, net cell proliferation and loss were 
examined for each PEG–ECM hydrogel over the 7 day culture period. The cell density in 
each PEG–ECM hydrogel following 7 days of culture was between 78 and 86% of the 
initial seeding density (Table 2), consistent with PEG hydrogel literature [4, 64, 70, 76, 
100-102]. Combined, the above data indicate that: (1) each hydrogel formulation 
maintained an osteogenic modulus throughout the study [81] and (2) differences in cell 
responses among formulations can be attributed to differences in the initial proteins 
tethered to the gel network, their interactions with other molecules and subsequent neo-
matrix deposition. 
 
 
Table 2.Comparison of the average thickness, mass, and cell density in discs of each PEG–ECM 
hydrogel formulation with time in culture.
a
 
 
 
 
a 
Results represent an average of n = 4 samples for each PEG–ECM formulation. 
*
 Significantly different from the corresponding day 0 value, p < 0.05. 
 
 
3.4.2. Cell differentiation 
Following 7 days of culture, cell differentiation was examined by quantitative 
ELISA or by cell counts (as validated in Figure 8). As shown in Figure 9, day 7 levels 
of various osteogenic markers indicated significant differences relative to day 0 and/or 
 
Gel type 
Thickness (mm) Mass of 8mm discs (mg) Cell density (x10
6
) 
Day 0 Day 7 Day 0 Day 7 Day 0 Day 7 
PEG-FN 0.55 ± 0.01 0.56± 0.01 29.1 ± 0.2 29.5± 0.2 1.01± 0.06 0.88± 0.08
* 
PEG-FG 0.55 ± 0.01 0.56± 0.01 29.2 ± 0.2 29.4± 0.5 0.96± 0.05 0.72± 0.02
* 
PEG-LN 0.54 ± 0.01 0.56± 0.01 29.2 ± 0.4 29.3± 0.3 1.01± 0.06 0.82± 0.02
*
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among hydrogel formulations. Specifically, cells in PEG–LN gels expressed 
significantly higher levels of the osteogenic transcription factor osterix than day 0 cells 
(p = 0.032), while osterix expression in PEG–FN gels could not be distinguished from 
day 0 levels. In addition, PEG–LN gels retained day 0 osteopontin expression levels, 
whereas osteopontin levels in day 7 PEG–FN gels had fallen to approximately half of 
day 0 levels (p = 0.005). Similarly, day 7  PEG–FN gels contained significantly lower 
levels of the bone ECM protein osteocalcin relative to PEG–FG (p = 0.042) and PEG–
LN (p = 0.002) gels, whereas PEG–FG and PEG–LN gels contained 2.4- and 2.9-fold 
greater osteocalcin levels than day 0 (p = 0.004 and p < 0.001, respectively). 
To assess the specificity of the osteogenic response associated with the PEG–FG 
and PEG–LN gels, mid-term markers of chondrogenesis, smooth muscle progression and 
adipogenesis were evaluated (Figure 10). Day 7 expression of smooth muscle 
transcription factor myocardin was similar to day 0 levels and across hydrogel 
formulations. In addition, day 7 levels of SM22α, a cytoskeletal protein associated with 
smooth muscle differentiation, could also not be distinguished among gel formulations 
or from day 0 levels. PPARγ expression was similar to day 0 levels across the day 7 gels, 
and the day 7 levels of the adipocyte intracellular protein A-FABP were statistically 
indistinguishable from day 0 levels and among formulations. Furthermore, day 7 
expression of chondrogenic transcription factor sox9 did not vary significantly with gel 
formulation or relative to day 0, and day 7 levels of the cartilage-associated ECM protein 
collagen II could also not be distinguished among the PEG–ECM gels or relative to day 
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0. Representative immunostaining images for proteins evaluated by cell counts 
(myocardin, PPARγ, and osteopontin) are given in Figure 11. 
 
 
 
Figure 9. Expression of osteogenic markers osterix, osteopontin and osteocalin by ELISA 
(osterix and osteocalcin) and cells counts (osteopontin). For ELISA assays, six samples per day 7 
formulation were analyzed. The day 0 ELISA sample number was n = 4. For cell counts, 
sections from 4-8 separate samples of each formulation were evaluated. Validation of the cell 
counting assessment method is given in Fig. 3. For the purpose of comparison, ELISA and cell 
count measures for each protein have been normalized to the corresponding measure for PEG-
FN gels.     
*
indicates a significant difference, p < 0.05 
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Figure 10. (A) Expression of myocardin and SM22α, as assessed by cell counting and ELISA 
methods, respectively. (B) Expression of PPARγ and A-FABP, as assessed by cell counting and 
ELISA methods, respectively. (C) Expression of sox9 and collagen II by ELISA. For ELISA 
assays, 6–9 samples per day 7 formulation were analyzed. The day 0 ELISA sample number was 
n = 4. For cell counts, sections from four separate samples of each formulation were evaluated. 
For the purpose of comparison, ELISA and cell count measures for each protein have been 
normalized to the corresponding measure for PEG–FN gels.  
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Figure 11. Representative images of day 7 immunostaining for myocardin, PPARγ and 
osteopontin. Positive staining is indicated by brown (PPARγ and osteopontin) or red 
(myocardin) coloration. Scale bar = 40 µm and applies to all images. 
 
 
3.5 DISCUSSION 
The aim of the present work was to compare the osteoinductivity of select ECM 
components in defined 3-D environments toward the improved design of osteogenic 
scaffolds. To avoid the use of exogenous growth factors, these ECM components were 
examined within the context of scaffolds with osteogenic moduli (~30 kPa) [81]. Present 
data indicated that both FG and LN enhanced the osteogenic response of encapsulated 
10T½ cells. Specifically, osteocalcin levels in day 7 PEG–FG and PEG–LN gels were 
~2.4- and 2.9-fold greater, respectively, than day 0 levels. In addition, expression of 
osterix, an osteoblast-specific transcription factor required for osteogenesis, was 
significantly elevated in day 7 PEG–LN gels relative to day 0 levels. In contrast, the day 
 43 
 
7 levels of markers for adipogenesis, chondrogenesis and smooth muscle lineage 
progression were not significantly different among formulations or relative to day 0, 
indicating that the osteogenic response associated with the PEG–FG and PEG–LN gels 
was specific.  
The present results are consistent with previous 2-D studies demonstrating LN to 
support higher active levels of the osteogenic transcription factor Cbfα1 than FN over a 
5 day culture time frame [72]. In addition, a study by Salaszynk et al. indicated that, in 
the absence of osteogenic media supplements, FN did not support human MSC matrix 
mineralization, in contrast to collagen I and vitronectin [103]. Indeed, they found little 
role for FN in stimulating osteogenic differentiation [65], beyond activation of alkaline 
phosphatase [103]. Similarly, Benoit et al. found that FN increased alkaline phosphatase 
production, but not osteopontin gene expression [76]. Although fibrin glue has been used 
extensively in bone tissue engineering [85, 104-113], literature presents conflicting 
reports regarding the osteoinductivity of fibrinogen. Specifically, while several studies 
have suggested that fibrin sealants promote osteogenesis [107, 109-111], other studies 
have reported negative effects when fibrin sealants were combined with coral granules 
[112, 113] and poly(lactide-co-glycolic acid) scaffolds [104]. These conflicting results 
may arise, in part, from differences in the material properties of the various fibrin-
containing scaffolds assayed. In the present study, we tightly controlled initial scaffold 
material properties as well as the temporal evolution of those properties in order to 
isolate the osteoinductive effect of FG from other matrix properties.  
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Moreover, since integrin-associated signaling has been demonstrated to play a 
key role in MSC osteogenic lineage progression [62-64, 69, 70, 73, 103], further studies 
conducted in our lab indicated that initial cell adhesion to functionalized FG was 
mediated by αv and α5 integrin subunits. In contrast, cell binding to FN was 
predominantly mediated by α2, αv and α5 integrin subunits, whereas LN interacted with 
α1, αv, α5 and α6 integrin subunits. Collectively, these results suggested that α1, α2, and α6 
integrin mediated adhesion might have strongly influenced the observed differentiation 
results. Nonetheless, osteogenesis represents a complex set of processes that are 
mediated by a number of factors. The interplay between these factors and the precise 
sequences leading to osteogenic commitment are not fully understood, and the present 
study examined only a limited subset of the interactions and a limited panel of the 
markers that characterize osteogenesis. In addition, the present study was conducted 
using cells derived from the mouse embryonic mesoderm. Although these cells 
demonstrate multipotency, their responses may not be indicative of the behavior of adult 
human mesenchymal stem cells.  
Despite these limitations, the cumulative ECM and phenotypic data indicate that 
LN may be the most appropriate of the biomolecules examined for promoting specific 
osteogenic differentiation within the context of scaffolds with osteoinductive moduli. 
Future studies will focus on exploring a broader range of time points and ECM protein 
concentrations as well as on examining potential synergy between various ECM 
components. 
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CHAPTER IV 
BIOMIMETIC HYDROGELS FOR THE FABRICATION OF TISSUE-ENGINEERED 
VASCULARIZED BONE CONSTRUCTS
*
 
 
4.1. OVERVIEW 
The results from the studies previously described in chapter III suggested that α1 
and α2 integrin cell adhesion is probably involved in mesenchymal stem cell 
osteogenesis. Nonetheless, in this particular case, the complexity of the interplay among 
the multiple signals provided to the cells made it difficult to determine whether α1 and 
α2 integrin adhesion was responsible for the differentiation profiles observed. The ideal 
system for evaluating the effect of a specific signal on cell behavior would allow the 
incorporation of the desired signaling in an appropriate three-dimensional (3D) protein 
structure without the additional signals associated with the biopolymer. In the present 
study, we employed a novel biomaterial platform based on a collagen-mimetic protein 
derived from group A Streptococcus, Scl2.28, which maintains the native triple helical 
structure of native collagen and allows the incorporation of desired integrin-binding 
motifs. We have engineered two Scl2 “daughters”,Scl2-2 (or DC2) and Scl2-3 (or DC3), 
                                                 
*
 Portion of this chapter was reprinted with permission from “Bioactive hydrogels based on Designer 
Collagens” by Cosgriff-Hernandez E, Hahn MS, Russell B, Wilems T, Munoz-Pinto D, Browning MB, 
Rivera J, Höök M, 2010, Acta Biomaterialia (2009) 3969-3977, Copyright 2010, Acta Materialia Inc. 
Published by Elsevier Ltd.  
Portion of this chapter was reprinted with permission from  “Multilayer Vascular Grafts Based on 
Collagen-Mimetic Hydrogels” by M.B. Browning, D. Dempsey, V. Guiza, J. Rivera, M. Höök, B. Russell, 
F. Clubb, M. Miller, T. Fossum, M. Hahn, E. Cosgriff-Hernandez,  2011, Acta Biomaterialia (2012), 8, 
1010-1021 (2012), Copyright 2011, Acta Materialia Inc. Published by Elsevier Ltd. 
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which incorporate α1β1 and/or α2β1 integrin-binding motifs based on the collagen 
sequences GF/LOGER [7, 8]. DC2 and DC3 were covalently crosslinked to 
poly(ethylene glycol) diacrylate (PEGDA) through established polymer chemistry in 
order to generate hybrid biosynthetic hydrogels.  
Our lab has previously shown that these hybrid PEGDA-DC gels support 
osteogenesis and therefore, could be potentially used in biomedical applications as 
osteoinductive scaffolds. Nonetheless, in the context of orthopedic applications, bone 
replacement materials are more effective if they also support capillary formation in 
addition to osteogenesis [9, 10]. Thus, a bone regeneration scaffold must be able to 
support endothelial cell adhesion and migration. In native vessels, collagen-based α1β1 
and α2β1 integrin binding motifs have been shown to modulate endothelial cell (EC) 
adhesion and phenotype [114]. Therefore, given that DC2 and DC3 incorporate α1β1 
and/or α2β1 integrin-binding motifs, the PEGDA-DC hybrid systems proposed in this 
work should have the ability to promote EC adhesion and spreading. The aim of this 
study was to test the ability of PEGDA-DC hydrogels to support EC adhesion, spreading 
and migration. The results from the adhesion and migration studies indicate that this 
novel hydrogel platform has the potential to improve on current options for the 
fabrication of highly functional tissue-engineered vascularized bone constructs.  
 
4.2. INTRODUCTION 
The results from the studies previously described in chapter III suggested that α1 
and α2 integrin cell adhesion is probably involved in mesenchymal stem cell 
 47 
 
osteogenesis. Nonetheless, in this particular case, the complexity of the interplay among 
the multiple signals provided to the cells made it difficult to determine whether α1 and 
α2 integrin adhesion was responsible for the differentiation profiles observed. The ideal 
system for evaluating the effect of a specific signal on cell behavior would allow the 
incorporation of the desired signaling in an appropriate three-dimensional (3D) protein 
structure without the additional signals associated with the biopolymer. In the face of 
this challenge, we have recently developed a novel biomaterial platform based on a 
collagen-mimetic protein derived from group A Streptococcus, Scl2.28. Scl2.28 or the 
“parent” DC (also known as DC1)  maintains the native triple helical structure of native 
collagen but contains no known cell signaling sequences [115, 116]. Thus, DC1 provides 
a “blank-slate” into which desired collagen-based, cell adhesion sequences can be 
programmed into specific regions of the triple helix via site-directed mutagenesis of the 
gene encoding for DC1 (Scl2.28) while maintaining the triple helical context natively 
associated with these motifs [117]. In conjunction with Dr. Russell of the Höök lab at 
Texas A&M Health Science Center, we have engineered two “daughter” DCs, Scl2-2 (or 
DC2) and Scl2-3 (or DC3), which incorporate α1β1 and/or α2β1 integrin-binding motifs 
based on the collagen sequences GF/LOGER [7, 8]. DC2 and DC3 were covalently 
crosslinked to poly(ethylene glycol) diacrylate (PEGDA) through established polymer 
chemistry in order to generate hybrid biosynthetic hydrogels. PEGDA was selected as 
the synthetic component of these hybrid hydrogels due to the fact that pure PEGDA gels 
intrinsically resist protein adsorption and cell adhesion [6, 117, 118], a feature that 
allowed to focus on the bioactive signals introduced into the hydrogels by the DCs. In 
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addition, PEGDA gels have been previously used in bone regeneration applications 
because of the broad tunability of their mechanical properties [2-5].  
Our lab has previously shown that these hybrid PEGDA-DC gels support 
osteogenesis. Specifically, following two weeks of culture, calcium deposition was 
significantly enhanced in human mesenchymal stem cells (hMSCs) encapsulated in 
PEGDA-DC2 gels relative to PEGDA-DC1 and PEGDA-DC3 samples. In addition to 
this, western blot assays revealed a significant increase in osterix and osteopontin 
expression in PEGDA-DC3 gels by ~ 1.4- and 1.2-fold, respectively, relative to PEG-
DC2 gels. Based on these promising results, our novel PEGDA-DC hydrogels could be 
potentially used in biomedical applications as osteoinductive scaffolds. Nonetheless, in 
the context of orthopedic applications, in vivo and in vitro studies have demonstrated 
that bone replacement materials are more effective if they also support capillary 
formation in addition to osteogenesis [9, 10]. In this way, the presence of endothelial 
cells may accelerate the defect healing process by improving cell nutrition in the 
scaffolds as well as in the defect site. Thus, a bone regeneration scaffold must be able to 
support endothelial cell adhesion and migration. In native vessels, collagen-based α1β1 
and α2β1 integrin binding motifs have been shown to modulate endothelial cell (EC) 
adhesion and phenotype [114]. Therefore, given that DC2 and DC3 incorporate α1β1 
and/or α2β1 integrin-binding motifs, the PEGDA-DC hybrid systems proposed in this 
work should have the ability to promote EC adhesion and spreading. However, this must 
be confirmed in our PEGDA-DC system. 
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The aim of this study was to test the ability of PEGDA-DC hydrogels to support 
EC adhesion, spreading and migration. EC adhesion studies confirmed cell-specific 
adhesion due to selective integrin binding to the two receptor binding motifs 
investigated. On the other hand, evaluation of EC migration speed demonstrated that 
PEGDA-DC hydrogels promoted higher migration speeds than PEGDA-collagen 
analogs and that migration speed was readily tuned by altering protein concentration. 
Collectively, these results indicate that this novel hydrogel platform has the potential to 
improve on current options for the fabrication of highly functional tissue-engineered 
vascularized bone constructs.  
 
4.3. MATERIALS AND METHODS 
4.3.1. Scl2 functionalization 
The Scl2.28 sequence was amplified and purified as previously described [119]. 
Scl2-1 (or DC1) served as a negative control with no binding sites for α1β1 or α2β1. 
Scl2-2 (or DC2) is a variant of this protein containing the sequence GFPGER that was 
generated by site directed mutagenesis as previously described [120]. Scl2 proteins and a 
rat tail collagen type I control were functionalized with photoreactive crosslink sites 
according to a protocol adapted from Sebra et al [120]. Scl2 proteins include ~9% lysine 
groups that allow for bioconjugation through the established NHS-lysine Ɛ-amino group 
reaction. Briefly, the proteins were reacted with acrylate-PEG-N-hydroxysuccinimide 
(Acr-PEG-NHS, MW 3500, Jenkem Technologies USA, Allen, TX) in 50 mM sodium 
bicarbonate buffer (pH 8.5). The Acr-PEG-NHS:NH2 molar ratio was 1:1, and the 
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reaction was allowed to proceed with stirring for 24 hours at room temperature. Acidic 
byproducts were removed via dialysis against 0.1M hydrochloric acid for 24 hours, and 
further purification was carried out with dialysis against deionized water for 24 hours 
(MWCO = 20,000). Functionalization of the modified proteins was confirmed with 
Fourier transform infrared (FTIR) spectroscopy and sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE), as previously shown [119]. 
 
4.3.2. Preparation of bioactive PEGDA-Scl2 hydrogels 
PEGDA was synthesized according to a method adapted from Hahn, et al . 
Briefly, 4 molar equivalents of acryloyl chloride were added dropwise to a solution of 
PEG (3.4 kDa or 6kDa; 1 molar equivalent) and triethylamine (2 molar equivalents) in 
anhydrous dichloromethane (DCM) under nitrogen. After the addition was complete, the 
reaction was stirred for 24 hours. The resulting solution was washed with 2M potassium 
bicarbonate (8 molar equivalents) and dried with anhydrous sodium sulfate. The product 
was precipitated in cold diethyl ether, filtered, and dried under vacuum. FTIR 
spectroscopy and proton nuclear magnetic resonance (1H-NMR) spectroscopy were used 
to confirm functionalization of PEGDA. Control and functionalized polymers were 
solution cast directly onto KBr pellets to acquire transmission FTIR spectra using a 
Bruker TENSOR 27 spectrometer. Successful acrylation was indicated by an ester peak 
at 1730 cm-1 and loss of the hydroxyl peak at 3300 cm-1 in the spectra. Proton NMR 
spectra of control and functionalized polymers were recorded on Mercury 300 MHz 
spectrometer using a TMS/solvent signal as an internal reference. All syntheses resulted 
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in percent conversions of hydroxyl to acrylate endgroups of greater than 85%. 1H-NMR 
(CDCl3): 3.6 ppm (m, -OCH2CH2-), 4.3 ppm (t, -CH2OCO-) 5.8 ppm (dd, -CH=CH2), 
6.1 and 6.4 ppm (dd, -CH=CH2).  
PEGDA, PEGDA-Scl2, and PEGDA-collagen hydrogels were prepared by 
dissolving PEGDA (10 or 20 wt%) and functionalized Scl2 or collagen (4, 6, 9, 12 or 15 
mg ml-1) in deionized water. A photointiator solution (1 mg Irgacure 2959 per 0.1 ml 
70% ethanol) was added at 1% volume of precursor solution. Solutions were pipetted 
into a mold and crosslinked by 6 min exposure to long wave UV light (Intelli Ray 
Shuttered UV Flood Light, Integrated Dispensing Solutions, Inc., 365 nm, 4 mW/cm2).   
 
4.3.3. Endothelial cell adhesion 
For cell adhesion studies, microtiter plates were coated with functionalized and 
unmodified Scl2-1, Scl2-2, and Scl2-3. Rat tail collagen I coated wells served as positive 
controls. Microtiter wells were coated with 1 µg per well of Scl2 1, Scl2-2, Scl2-3, or rat 
tail derived collagen type I (Cultrex R&D) in PBS overnight at 4°C. The Scl2 protein 
solutions were filter-sterilized using a 0.22 µm PDVF membrane (Millipore) prior to 
application to the microtiter plate. For each Scl2 protein, 15 wells (3 wells per cell type 
examined) were coated. After blocking with PBS containing 1% BSA for 1 h, the wells 
were rinsed extensively with PBS and cells were seeded onto the coated surfaces at 
20000 cells/cm2.  
 Prior to seeding, cells were adapted to serum free media (DMEM containing 
1mM CaCl2 and 1mM MgCl2) for 3 h, after which cells were harvested by brief 
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exposure to 0.125% trypsin (Mediatech) and resuspended in serum free media 
supplemented with 0.2% BSA. Following 3 h exposure to the coated surfaces at 37 °C / 
5% CO2, cells were fixed with 4 % paraformaldehyde and stained with rhodamine 
phalloidin (Invitrogen) and SybrGreen (Invitrogen). Rhodamine- labeled phalloidin in 
combination with SybrGreen were chosen as cell markers because phalloidin binds to F-
actin, which is present in abundance in cell cytoplasm, and SybrGreen binds DNA, 
which indicates the location of the nucleus of each cell. Representative fluorescence 
images were obtained using a Zeiss Axiovert microscope.   
 
4.3.4. Quantitative analysis of cell adhesion and spreading 
 Fluorescence images (3 images per sample, 3 samples per protein) of SybrGreen 
and rhodamine phalloidin stained cells seeded onto coated tissue culture plastic were 
utilized to quantify the extent of cell adhesion and spreading. The number of cell nuclei 
per image was used as a quantitative assessment of cell adhesion on each test surface and 
was assessed by two independent observers. Average cell spreading, or cell area, was 
quantified by applying the Photoshop “magic wand” tool to the image background and 
adjusting the tool tolerance so that all extracellular regions were selected. The histogram 
function was then utilized to evaluate the extracellular pixels. The average pixels per cell 
(Acell) for that image was then quantified as follows: Acell = (total image pixels – 
extracellular pixels)/(total image nuclei). Pixels were then converted to microns using 
known objective scaling. Data are reported as mean ± standard error of the mean 
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4.3.5. Endothelial cell migration 
For the PEGDA-Scl2 hydrogels to support vascularization, they must support EC 
adhesion and enable sufficient EC migration. To analyze EC migration on PEGDA-Scl2 
hydrogels, sterile filtered PEGDA-Scl2-2 (10 wt% PEGDA, 3.4 kDa, 6 or 12 mg 
protein/ml) and PEGDA-collagen (10 wt% PEGDA, 3.4 kDa, 2 or 4 mg protein/ml) 
hydrogels were prepared between glass plates separated by 0.5 mm spacers. The 
resulting hydrogels were immersed in PBS for 24 h, after which a set of 2.54 cm 
punches were collected from the swollen gels. 
Bovine aortic endothelial cells (BAECs) were harvested and seeded onto the 
hydrogels at 10,000 cells cm-2. Gels were cultured for 24 h at 37 °C/5% CO2 to allow 
for cell adhesion and equilibrium cell spreading. EC migration was then monitored for 1 
h at 5 min intervals in at least three randomly selected locations of each hydrogel 
formulation using a Zeiss Axiovert microscope. For determination of single cell 
migration parameters, only cells that remained in isolation (> 100 µm from other cells) 
were measured. Cell centroid position was determined based on cell outlines using 
Photoshop. These centroids were then used to calculate the mean-square displacement 
(MSD) for a range of time intervals. The speed, S, and direction persistence time (P) 
were determined by fitting the MSD (〈  〉) and the time interval, t, to the persistent 
random walk equation: using nonlinear least squares regression analysis:  
〈  〉          (    (
 
 ))  
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4.4. RESULTS 
4.4.1. Endothelial cell adhesion and spreading 
As shown in Figure 12, ECs strongly spread on functionalized collagen coated 
surfaces. Furthermore, functionalized Scl2-2 and Scl2-3 coated surfaces mediated EC 
attachment and spreading whereas EC adhesion on Scl2-1 coated wells was minimal. 
Figure 13 shows EC adhesion and spreading on functionalized Scl2 versus collagen on 
both coated tissue culture polystyrene and PEGDA-Scl2 hydrogels. In the case of coated 
surfaces, EC adhesion to Scl2-2, Scl2-3 and collagen was significantly higher than what 
was found for the negative control. Additionally, cell spreading was significantly higher 
in Scl2-2 and collagen samples relative to the BSA negative controls. On the other hand, 
regarding hydrogel surfaces, EC adhesion and spreading on Scl2-2, Scl2-3 and collagen 
was significantly higher than their PEGDA negative controls. Collectively, these results 
indicate that Scl2-2 and Scl2-3 appear to mediate the attachment and spreading of ECs 
on polystyrene as well as on hydrogel surfaces.   
 
 
 
Figure 12. High binding polystyrene 96 well plates were coated with PEG-functionalized Scl2-
1, Scl2-2, Scl2-3, and functionalized type I collagen at 1 µg protein per well. ECs were seeded at 
a density of 20000 cells/cm2 and allowed to spread for 3 hours. Scale bar applies to all images 
and equals 100 µm. 
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4.4.2. Endothelial cell migration  
The migration of endothelial cells is one of the most relevant processes in 
vasculogenesis. In the absence of preexisting vessels, they are derived from endothelial 
precursors . The endothelial cells that contribute to the primary vascular plexus are 
initially scattered and eventually assemble following migration, at the location of the 
developing vessel. Therefore, in addition to providing biocompatibility and supporting 
osteoinductivity, PEGDA-Scl2 hydrogels must be able to promote EC migration. As an 
initial evaluation of the potential of PEGDA-Scl2-2 gels to promote EC migration, the 
movements of ECs seeded onto PEGDA-Scl2-2 hydrogels were tracked over 1 hour and 
PEGDA-Scl2-2 and PEGDA-collagen hydrogels was unaffected by a 2 fold increase in 
protein concentration, and average EC spreading on PEGDA-Scl2-2 hydrogels was 
lower than that supported by the PEG-collagen controls, Figure 15A. However, EC 
migration rates on the hydrogels were affected by both type and concentration of protein, 
Figure 15B. Specifically, an increase in the concentration of Scl2-2 from 6 to 12 mg of 
compared to those on PEGDA-collagen hydrogels, Figure 14. EC spreading on both 
protein per ml of hydrogel solution resulted in a 3 fold increase in EC migration rates 
from 4.2 ± 2.2 µm min-1 to 13.2 ± 4.2 µm min-1. A corresponding increase in collagen 
concentration (2 to 4 mg of protein per ml, based on an equivalent number of binding 
sites relative to 6 and 12 mg of Scl2-2 per mL), did not cause a significant increase in 
migration rates. Additionally, migration speeds on PEGDA-Scl2-2 hydrogels were 
increased relative to those on equivalent PEGDA-collagen hydrogels. As cell spreading 
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increases, the resulting increased contact area generally enhances cell ability to resist 
detachment. 
 
 
 
Figure 13.  Relative cell adhesion and spreading on functionalized Scl2 versus collagen on 
coated tissue culture polystyrene (A) and PEGDA-Scl2 hydrogels (B). *, indicates a statistically 
significant different with the corresponding control (BSA for A  and PEG for B), p < 0.05. 
 
 
Therefore, cell spreading can be used as a preliminary indication of adhesion strength on 
a surface. From this, it can be inferred that ECs on the 12 mg Scl2-2 ml-1 surface had 
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similar adhesion strength to those on the 6 mg Scl2-2 ml-1 surface while achieving 
higher migration rates. These studies demonstrated that Scl2-2 concentration can be used 
to control EC migration rates, and PEGDA-Scl2-2 hydrogels have the potential to 
improve upon the rate of EC migration relative to collagen-based systems. Future studies 
will include the use of human ECs rather than bovine ECs. 
 
 
 
Figure 14. Micrographs used to track endothelial cell centroid position to determine migration 
rates on (A) PEG-Scl2-2 hydrogels and (B) PEG-collagen hydrogels. The scale bar applies to all 
images, and images are shown at 10 min intervals. 
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Figure 15. Endothelial cell spreading (A) and  rate of EC migration (B). Levels of EC spreading 
on PEG-collagen hydrogels are approximately twofold higher than on PEG-Scl2-2 hydrogels. 
EC migration rates increased approximately threefold with increased concentration of Scl2-2, 
and average migration speeds on Scl2-2 gels were approximately 10-fold greater than those 
observed on equivalent PEG-collagen gels. n = 6; mean ± standard error of mean displayed; ∗ p 
> 0.05 relative to 6 mg Scl2-2 ml−1 sample. 
 
 
4.5. CONCLUSIONS 
In the current study, novel PEGDA-Scl2 hydrogel systems were fabricated. In 
addition to the EC adhesion and spreading experiments on PEGDA-Scl2 hydrogels, the 
current studies demonstrate that EC migration speed can be tuned on these hydrogels by 
modulating Scl2-2 concentration. Furthermore, the observed migration speeds were 
higher than those observed on hydrogels containing equivalent levels of collagen. 
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Cumulatively, these results indicate that PEGDA-Scl2-2 hydrogels can support EC 
adhesion, spreading and migration, which are key mechanisms for the generation of 
blood vessels. In addition to their osteoinductive properties, the fact that our PEGDA-
Scl2-2 scaffolds have the ability to support vasculogenesis provides these novel tissue 
engineering platforms with high potential in the fabrication of improved vascularized 
bone constructs. Further studies will be conducted using human ECs, instead of BAECs 
to optimize EC adhesion and migration on PEGDA-Scl2 hydrogels.  
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CHAPTER V 
CONCLUSIONS  
 
The accomplished work represents a contribution towards the development of 
novel materials that provide enhanced versatility for orthopedic applications. 
Specifically, evaluation of PAH/PAA coatings on magnetic NiMnSn shape memory 
alloys indicated that the presence of the polyelectrolyte coatings improved alloy 
cytocompatibility via reducing ion release. Given that coating stability and integrity are 
critical to reducing alloy cytotoxicity, the investigation of different methods to improve 
coating long-term integrity and surface adhesion is indispensable for the design of more 
biocompatible NiMnSn MSMAs.  
On the other hand, in the context of bone regeneration applications, PEGDA 
based hydrogel systems proved useful tools for the examination of the effect of 
extracellular matrix (ECM) biomolecules on mesenchymal stem cell (MSC) osteogenic 
differentiation. Particularly, by using these hydrogel platforms, it was possible to 
compare the osteoinductivity of ECM proteins that had been previously associated with 
bone fracture and healing. Present data indicated that both FG and LN enhanced the 
osteogenic response of encapsulated 10T½ cells. Specifically, osteocalcin levels in day 7 
PEG–FG and PEG–LN gels were ~2.4- and 2.9-fold greater, respectively, than day 0 
levels. In addition, expression of osterix, an osteoblast-specific transcription factor 
required for osteogenesis, was significantly elevated in day 7 PEG–LN gels relative to 
day 0 levels. In contrast, the day 7 levels of markers for adipogenesis, chondrogenesis 
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and smooth muscle lineage progression were not significantly different among 
formulations or relative to day 0, indicating that the osteogenic response associated with 
the PEG–FG and PEG–LN gels was specific. Moreover, further studies conducted in our 
lab indicated that α1, α2, and α6 integrin mediated adhesion might have strongly 
influenced the observed differentiation results. Cumulatively, our data indicate that LN 
may be the most appropriate of the biomolecules examined for promoting specific 
osteogenic differentiation within the context of scaffolds with osteoinductive moduli. 
Nonetheless, exploration of a broader range of time points and ECM protein 
concentrations as well as examination of potential synergy between various ECM 
components would provide a better understanding of MSC osteogenic responses to 
specific ECM constituents. 
Finally, the ideal system for evaluating the effect of a specific signal on cell 
behavior should allow the incorporation of the desired signaling in an appropriate three-
dimensional (3D) protein structure without the additional signals associated with the 
biopolymer. Therefore, we employed a novel biomaterial platform based on a collagen-
mimetic protein derived from group A Streptococcus, Scl2.28, which maintains the 
native triple helical structure of native collagen and allows the incorporation of desired 
integrin-binding motifs. Following the development of two Scl2 proteins, which 
incorporate α1β1 and/or α2β1 integrin-binding motifs based on the collagen sequences 
GF/LOGER [7, 8], our lab has been able to show that hybrid PEGDA-Scl2 hydrogels 
support hMSC osteogenic differentiation. However, since bone replacement materials 
are more effective if they also support capillary formation in addition to osteogenesis, 
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we evaluated the ability of PEGDA-Scl2 hybrid scaffolds to support EC adhesion, 
spreading and migration. Results from these experiments demonstrated that EC 
migration speed can be tuned on these hydrogels by modulating Scl2-2 concentration. 
Furthermore, the observed migration speeds were higher than those observed on 
hydrogels containing equivalent levels of collagen. Cumulatively, these results indicate 
that PEGDA-Scl2-2 hydrogels can support EC adhesion, spreading and migration, which 
are key mechanisms for the generation of blood vessels. In addition to their 
osteoinductive properties, the fact that our PEGDA-Scl2-2 scaffolds have the ability to 
support vasculogenesis will provide a more controlled platform which will serve as a 
foundation for the fabrication of more efficient vascularized bone constructs for 
orthopedic applications.  
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